Avalon GloboCare Corp. (NASDAQ:ALBT) Sees Significant Increase in Short Interest

Avalon GloboCare Corp. (NASDAQ:ALBT) was the recipient of a large growth in short interest in April. As of April 15th, there was short interest totalling 137,400 shares, a growth of 64.7% from the March 31st total of 83,400 shares. Based on an average daily volume of 170,800 shares, the days-to-cover ratio is presently 0.8 days. Currently, 2.8% of the shares of the stock are sold short.

Avalon GloboCare Trading Down 2.6 %

ALBT opened at $0.27 on Friday. The stock has a market capitalization of $3.03 million, a P/E ratio of -0.17 and a beta of 0.19. Avalon GloboCare has a 12-month low of $0.25 and a 12-month high of $2.42. The stock has a 50-day moving average price of $0.34 and a 200-day moving average price of $0.46.

Avalon GloboCare (NASDAQ:ALBT) last issued its earnings results on Monday, April 15th. The company reported ($0.90) earnings per share for the quarter. The company had revenue of $0.32 million during the quarter.

Avalon GloboCare Company Profile

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.